Market Analysis

March 2014

Vascular Access Devices | US | 2014 | Market Analysis

Introduction:

Overall, rising unit sales—as a result of an increasing patient pool—and the uptake of premium-priced products will spur revenue growth in the US vascular access device market.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for vascular access devices in the US across a 10-year period.

Millennium Research Group has up-to-date reports on a wide range of medical device markets worldwide.

Questions Answered in This Report:

  *   Short PIVCs come in standard and safety varieties and are used in both acute and alternative care settings.

How are initiatives to reduce needlestick injuries affecting the market for short PIVCs?

How will market growth differ between acute and alternative care settings through 2022?

  *   The risk of catheter-related BSIs is a prominent issue when it comes to the use of vascular access devices, and reducing this risk will continue to be a focus of healthcare facilities and manufacturers.

What effects are initiatives and guidelines to reduce BSIs having on device usage?

How will device usage shift between short PIVCs, PICCs, CVCs, and implantable ports?

How will the markets for antimicrobial CVCs and dialysis catheters perform over the forecast period?

  *   Power-injectable PICCs, CVCs, and implantable ports enable physicians to inject the contrast media required for CT scans, thereby reducing the need for additional catheters.

To what extent will power-injectable PICCs, implantable ports, and Huber needles be adopted and how will this affect unit sales and revenues in their respective markets?

What effects are power-injectable devices having on the CVC market?

  *   The development of novel technologies will contribute to market growth and will help companies to remain competitive or develop a competitive advantage over others.

How will new antithrombogenic devices impact the markets for PICCs, CVCs, implantable port, and dialysis catheters?

How are tip positioning systems affecting the competitive landscape for PICCs?

Scope:

Geographies Covered: US

Products Covered: Our analysis uses the following breakdown of products:

Product Type

Short PIVCs

Facility Type

Acute

Product Subtype

Standard

Safety

Alternative

Product Subtype

Standard

Safety

PICCs

Product Subtype

Standard

Operator

Interventional Radiologist

Nurse

Power-Injectable

Operator

Interventional Radiologist

Nurse

CVCs

Product Subtype

Acute

Product Feature

Standard

Antimicrobial

Tunneled

Product Feature

Standard

Power-Injectable

Dialysis Catheters

Product Subtype

Acute

Product Feature

Standard

Antimicrobial

Chronic

Product Feature

Standard

Antimicrobial

Implantable Ports

Product Feature

Single-Lumen

Product Subtype

Standard

Power-Injectable

Dual-Lumen

Product Subtype

Standard

Power-Injectable

Huber Needles

Product Subtype

Conventional

Safety

Product Subtype

Standard

Power-Injectable

Note: The sales of Huber needles are not included as part of overall vascular access device market totals.

In the "Dialysis Catheter Market" chapter, the ESRD incident and prevalent populations are shown, along with the ESRD treatment types and modes of vascular access for ESRD hemodialysis cases.

ESRD Treatments Covered

Patients

Population

Incident

Prevalent

Treatment Type

Hemodialysis

Initial and Follow-Up Mode of Vascular Access

Dialysis Catheter

AV Fistula

AV Graft

PD

Kidney Transplant

Note: Initial mode refers to the initial mode of vascular access; follow-up mode refers to the mode of vascular access after 90 days.

Market Forecast Features: Based on primary research with industry professionals, Millennium Research Group uses its proprietary forecasting model to provide an in-depth examination of current and future trends in unit sales, ASPs, and market values over a 10-year period (2012–2022).

Competitive Analysis: Millennium Research Group provides a detailed analysis of the competitive landscape and market shares for leading competitors.

Authors:

Jonathan Sawatsky, M.Biotech

Contributors
April Chan
Samuli Heilala, M.Sc.
Veronica Ross



Search Reports

CONTACT US
Email Opt-in: I consent to receive e-mails from DRG regarding healthcare market information, product announcements, promotions, webinar and seminar invitations and other messages. I understand that I may withdraw my consent and unsubscribe or update my email preferences at any time. Please read our Terms of Use and Privacy Policy and contact us with any questions.

Mentioned in this report:

  • AngioDynamics
  • Argon Medical Devices
  • Baxter
  • B. Braun
  • BD
  • Cardinal Health
  • Cook Medical
  • Covidien
  • C. R. Bard
  • CryoLife
  • Edwards Lifesciences
  • Getinge Group
  • Hemosphere
  • Hospira
  • Interface Biologics
  • Kawasumi Laboratories
  • Medcomp
  • Merit Medical Systems
  • Navilyst Medical
  • Nipro
  • PEROUSE MEDICAL
  • pfm medical
  • r4 Vascular
  • Semprus BioSciences
  • Smiths Medical
  • Teleflex Medical
  • Terumo
  • Vygon
  • W. L. Gore
Decision Resources Group brands include: